Assure Holdings Corp. (Assure), a provider of intraoperative neuromonitoring and remote neurology services, has issued a reminder to its stockholders to vote for the proposed increase in authorized shares. The special meeting for this vote is scheduled for May 14, 2024. As of the current voting results, over 95% of the votes received are in favor of the increase, but more votes are needed to reach the required 50% of outstanding shares. CEO John Farlinger emphasized the importance of every vote, including those from stockholders with smaller positions, to avoid delays in the completion of the increase. The company has filed a definitive proxy statement with the SEC and has provided stockholders with the necessary materials to vote. Assure has also engaged Advantage Proxy...Show More

Assure Holdings Corp. (Assure), a provider of intraoperative neuromonitoring and remote neurology services, has issued a reminder to its stockholders to vote for the proposed increase in authorized shares. The special meeting for this vote is scheduled for May 14, 2024. As of the current voting results, over 95% of the votes received are in favor of the increase, but more votes are needed to reach the required 50% of outstanding shares. CEO John Farlinger emphasized the importance of every vote, including those from stockholders with smaller positions, to avoid delays in the completion of the increase. The company has filed a definitive proxy statement with the SEC and has provided stockholders with the necessary materials to vote. Assure has also engaged Advantage Proxy, Inc. to assist stockholders with voting and to reach out to those who have not yet voted. The company highlights that failure to vote or abstention will count as a vote against the proposal. Assure's mission is to provide exceptional surgical care and a positive patient experience, and the increase in capital is deemed critical for its continued success.